Zobrazeno 1 - 10
of 45
pro vyhledávání: '"G. J. Wolbink"'
Autor:
L. Boekel, F. Hooijberg, E. H. Vogelzang, P. L. Klarenbeek, W. H. Bos, S. W. Tas, G. J. Wolbink
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-6 (2021)
Abstract Clinical research projects often use traditional methods in which data collection and signing informed consent forms rely on patients’ visits to the research institutes. However, during challenging times when the medical community is in di
Externí odkaz:
https://doaj.org/article/93bcf9ee9f314bc7b767227da5f2dbca
Autor:
M. Leeuw, S. Atiqi, F. De Vries, L. Boekel, F. Hooijberg, M. Nurmohamed, G. J. Wolbink, C. Krieckaert
Publikováno v:
Annals of the Rheumatic Diseases. 81:1104.1-1105
BackgroundTherapeutic Drug Monitoring (TDM) is a tool to determine the optimal dose of a drug for individual patients using measurement of blood concentrations and, optionally, anti-drug antibodies (ADA). In the field of rheumatology interest in appl
Autor:
L. Boekel, E. Stalman, L. Wieske, F. Hooijberg, Y. Besten, M. Leeuw, S. Atiqi, L. Kummer, K. van Dam, M. Steenhuis, Z. van Kempen, J. Killestein, W. Lems, S. Tas, R. van Vollenhoven, M. Nurmohamed, M. Boers, M. van Ham, T. Rispens, T. Kuijpers, F. Eftimov, G. J. Wolbink
Publikováno v:
Annals of the Rheumatic Diseases. 81:118-118
BackgroundConcerns have been raised regarding risks of COVID-19 breakthrough infections in vaccinated patients with immune-mediated inflammatory diseases (IMIDs) treated with immunosuppressants, but data on COVID-19 breakthrough infections in these p
Publikováno v:
Annals of the Rheumatic Diseases. 81:561.2-561
BackgroundPatients with inflammatory rheumatic diseases as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and spondyloarthritis (SpA) are at higher risk for developing cardiovascular diseases (CVD) than the general population. This is due to a
Autor:
S. Atiqi, M. Leeuw, F. Hooijberg, L. Boekel, F. Loeff, K. Bloem, C. Krieckaert, A. De Vries, M. Nurmohamed, T. Rispens, G. J. Wolbink
Publikováno v:
Annals of the Rheumatic Diseases. 81:601.2-602
BackgroundImmunogenicity of adalimumab (ADL) has been the subject of extensive research, with the primary focus on its incidence, antibody titers and effects on clinical outcome. However, the temporal evolution of antibodies, i.e. dynamic and variati
Autor:
G. J. Wolbink, Caspar Schalkwijk, Joke W. Baars, John Wagstaff, Henk van den Bosch, C. Erik Hack
Publikováno v:
Cancer Immunology, Immunotherapy. 41:287-292
Autor:
S, Arends, H R, Lebbink, A, Spoorenberg, L B, Bungener, C, Roozendaal, E, van der Veer, P M, Houtman, E N, Griep, P C, Limburg, C G M, Kallenberg, G J, Wolbink, E, Brouwer
Publikováno v:
Clinical and experimental rheumatology. 28(5)
To investigate the influence of antibody formation to TNF-α blocking agents on the clinical response in AS patients treated with infliximab (IFX), etanercept (ETA), or adalimumab (ADA), and to investigate the development of ANA, ANCA, and anti-dsDNA
Autor:
L A van de Stadt, A van der Horst, M de Koning, W H Bos, G J Wolbink, R J van de Stadt, G J M Pruijn, B A C Dijkmans, D van Schaardenburg, D Hamann
Publikováno v:
de Stadt, L A V, Horst, A, Koning, M, Bos, W H, Wolbink, G J J, de Stadt, R J V, Pruijn, G J M, Dijkmans, B A C, van Schaardenburg, D & Hamann, D 2010, ' The Extent of the Anti-Citrullinated Protein Antibody Repertoire Is Associated with Arthritis Development in Seropositive Arthralgia Patients ', Annals of the Rheumatic Diseases, vol. 69, pp. A13 . https://doi.org/10.1136/ard.2010.129585f
Annals of the Rheumatic Diseases, 69. BMJ Publishing Group
Annals of the Rheumatic Diseases, 69. BMJ Publishing Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1979ee1c284aea5ec5e6a04f290afa0
https://research.vumc.nl/en/publications/ebff428f-f7e1-466a-b26d-76fc89241120
https://research.vumc.nl/en/publications/ebff428f-f7e1-466a-b26d-76fc89241120
Autor:
G. J. Wolbink, J. W. Baars, J. Wagstaff, A. Eerenberg, C. E. Hack, R. W. Faint, M. Mythen, I. J. Mackie, S. J. Machin, C. Routsi, S. Zakynthinos, B. Haviaras, A. Mavromatis, A. Armaganidis, B. Kadas, Ch. Roussos, D. Annane, M. C. Jars-Guincestre, F. Paraire, J. C. Raphaël, L. Lind, J. Mälstam, G. Skoog, J. -L. Teboul, J. Depret, N. Leger, D. Douguet, M. Zelter, A. Mercat, Ch. Richard, F. Saulnier, A. Durocher, G. Cadelis, F. Herengt, F. Wattel, B. Kugler, K. Träger, M. Holland, Th. Schricker, M. Georgieff, R. G. J. Westendorp, A. N. Roos, R. Simons, M. Frölich, A. E. Meinders, M. Lichtwarck-Aschoff, J. Aschenbrenner, G. Zimmermann, R. Senekowitsch, U. J. Pfeiffer, G. Blümel, A. T. Lovell, G. C. Hanson, P. J. Jensen, P. K. Andersen, C. Thøgersen, J. I. Poelaert, J. A. Everaert, D. P. Vogelaers, J. M. Decruyenaere, F. A. Colardyn, A. C. Timmins, M. Giles, C. J. Hinds, N. Maynard, D. Bihari, R. Mason, G. Baldock, I. McColl, D. Mathieu, R. Neviere, M. Fleyfel, J. Zaknun, L. Fridrich, D. Heute, S. Dyrk, A. Stoeger, M. Seyr, N. Mutz, G. Riccabona, J. Y. Lefrant, G. Aya, J. E. de la Coussaye, B. Bassoul, J. P. Auffray, J. J. Eledjam, S. Leucht, H. W. Kisch, R. Goller, J. P. Belot, B. Valtier, D. Mottin, D. Payen, A. Rubini, Del Monte, I. Attar, E. Catena, G. Rattazzi, G. L. Alati, P. Polisca, F. Turani, M. D. Pierri, L. Sommariva, Peppo A. de Penta, D. F. Colella, E. Zupancich, P. A. Gioffrè, L. Chiariello, A. Descorps-Declère, J. Hollande, M. Beaussier, O. Mimoz, J. Duranteau, A. Edouard, K. Samii, J. N. Drault, P. Marzollo, P. Sebastiano, M. Mariotti, P. Burnier, R. Chioléro, J. -J. Goy, Y. Schütz, H. Gombotz, H. Metzler, J. Plaza, J. Berger, W. F. List, D. C. Angus, N. M. Lidsky, L. M. Dotterweich, M. R. Pinsky, P. Evrard, B. de Ruyter, A. Dive, M. Gonzalez, L. Jacquet, E. Installé
Publikováno v:
Intensive Care Medicine. 18:S173-S180
Autor:
T, van der Poll, S J, van Deventer, C E, Hack, G J, Wolbink, L A, Aarden, H R, Büller, J W, ten Cate
Publikováno v:
Blood. 79:693-698
Tumor necrosis factor (TNF) has been implicated as a proximal mediator of the septic syndrome. To evaluate the possible role of TNF in leukocyte activation in septicemia, we performed a cross-over saline- controlled study in six healthy men who were